Publications

5543 Results

The relationship between a priori defined prognostic risk groups and overall survival (OS) in men with metastatic hormone sensitive prostate cancer (mHSPC)

Authors
H Halabi;A Roy;S Guo;L Rydzewska;P Godolphin;M Hussain;C Tangen;IM Thompson;M Carducci;M Smith;M Morris;G Gravis;D Dearnlavey;P Verhagen;T Goto;J Tierney;N James;N James;M Buyse;C Sweeney
Journal / Conference
J Clin Oncol 41, 2023 (suppl 16; abstr 5073); ASCO Annual Meeting (June 2-6, 2023, Chicago, IL), poster
Year
2023
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9346

Relationship between ABO blood group alleles and pancreatic cancer is modulated by secretor (FUT2) genotype, but not Lewis antigen (FUT3) genotype

Authors
J Kim;C Yuan;L Amundadottir;B Wolpin;A Klein;H Risch;P Kraft;Panc Ca Consort (P Goodman)
Journal / Conference
Cancer Epidemiology, Biomarkers, and Prevention Sep 1;32(9):1242-1248
Year
2023
Research Committee(s)
Prevention, Screening, and and Surveillance
PMID
PMID37342060
PMC
PMC10527950
Study Number(s)
S0000

A genetic locus within the FMN1/GREM1 gene region interacts with body mass index in colorectal cancer risk

Authors
E Aglago;A Kim;Y Lin;C Qu;M Evangelou;Y Ren;J Morrison;D Albanes;V Arndt;E Barry;J Baurley;S Berndt;S Bien;D Bishop;E Bouras;H Brenner;D Buchanan;A Budiarto;R Carreras-Torres;G Casey;T Cenggoro;A Chan;J Chang-Claude;X Chen;D Conti;M Devall;N Dimou;D Drew;J Figueiredo;S Gallinger;G Giles;S Gruber;A Gsur;M Gunter;H Hampel;S Harlid;A Hidaka;T Harrison;M Hoffmeister;J Huyghe;M Jenkins;K Jordahl;A Joshi;E Kawaguchi;T Keku;A Kundaje;S Larrson;L LeMarchand;J Lewinger;B Lynch;B Mahesworo;M Mandic;M Obon-Santacana;M Moreno;N Murphy;H Nan;R Nassir;P Newcomb;S Ogino;J Ose;R Pai;J Palmer;N Papadimitriou;B Pardamean;A Peoples;E Platz;J Potter;R Prentice;G Rennert;E Ruiz-Narvaez;L Sakoda;P Scacheri;S Schmidt;R Schoen;A Shcherbina;M Slattery;M Stern;Y Su;C Tangen;S Thibodeau;D Thomas;Y Tian;C Ulrich;F van Duijnhoven;B Van Guelpen;K Visvanathan;P Vodicka;J Wang;E White;A Wolk;M Woods;H Wu;N Zemlianskaia;L Hsu;W Gauderman;U Peters;K Tsilidis;P Campbell
Journal / Conference
Cancer Research Aug 1;83(15):2572-2583
Year
2023
Research Committee(s)
Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
PMID
PMID37249599
PMC
PMC10391330
Study Number(s)
S0000

Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries

Authors
C Fernandez-Rozadilla;M Timofeeva;Z Chen;P Law;M Thomas;S Schmidt;D Albanes;E Platz;H-J Lenz;C Tangen;S Gruber;I Tomlinson;W Zheng;M Dunlop;R Houlston;U Peters
Journal / Conference
Nat Genet. Jan;55(1):89-99
Year
2023
Research Committee(s)
Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
Study Number(s)
S0000

Sleep and cancer recurrence and survival in patients with resected Stage III colon cancer: findings from CALGB/SWOG 80702 (Alliance)

Authors
S Lee;C Ma;Q Shi;J Meyer;P Kumar;F Coutoure;P Kuebler;D Lewis;B Tan;E O'Reilly;A Shields;J Meyerhardt
Journal / Conference
Br J Cancer, Aug;129(2):283-290
Year
2023
Research Committee(s)
Gastrointestinal
PMID
PMID37179438
PMC
PMC10338523
Study Number(s)
CTSU/C80702

Baseline quality of life is a strong and independent prognostic factor for overall survival in metastatic colorectal cancer

Authors
P McGarrah;J Hubbard;P Novatny;M Branda;D Sargent;R Morton;C Fuchs;R Ramanathan;S Williamson;B Findlay;S Alberts;R Goldberg;J Sloan
Journal / Conference
Cancer Control Jan-Dec;30:10732748231185047
Year
2023
Research Committee(s)
Gastrointestinal
PMID
PMID37339926
PMC
PMC10286175
Study Number(s)
N9741

Long term outcomes from a phase II study of neoadjuvant chemotherapy for muscle invasive bladder cancer (SWOG S1314; NCT02177695)

Authors
T Flaig;C Tangen;S Daneshmand;A Alva;MS Lucia;D McConkey;D Theodorescu;A Goldkorn;M Milowsky;R Bangs;G MacVicar;B Bastos;J Fowles;D Gustafson;M Plets;I Thompson;S Lerner
Journal / Conference
European Urology Sep;84(3):341-347
Year
2023
Research Committee(s)
Genitourinary
PMID
PMID37414705
PMC
PMC10659139
Study Number(s)
S1314

Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer (Alliance A031201 Trial)

Authors
M Morris;G Heller;D Hillman;O Conway;C Ryan;E Antonarakis;A Bryce;O Hahn;H Beltran;A Armstrong;L Schwartz;L Lewis;J Beumer;B Langevin;E McGary;P Mehan;A Goldkorn;B Roth;H Xiao;C Watt;M Taplin;S Halabi;E Small
Journal / Conference
Journal of Clinical Oncology Jun 20;41(18):3352-3362
Year
2023
Research Committee(s)
Genitourinary
PMID
PMID36996380
Study Number(s)
CTSU/A031201

Preoperative Treatment of Locally Advanced Rectal Cancer

Authors
D Schrag;Q Shi;M Weiser;M Gollub;L Saltz;B Musher;J Goldberg;T Al Baghdadi;K Goodman;R McWilliams;J Farma;T George;H Kennecke;M Montemurro;G Nelson;B Colgrove;V Gordon;A Venook;E O'Reilly;J Meyerhardt;A Dueck;E Basch;G Chang;H Mamon
Journal / Conference
N Engl J Med. Jul 27;389(4):322-334
Year
2023
Research Committee(s)
Gastrointestinal
PMID
PMID37272534
PMC
PMC10775881
Study Number(s)
CTSU/N1048

Patient-reported outcomes during and after treatment for locally advanced rectal cancer in the N1048 PROSPECT trial

Authors
E Basch;A Dueck;S Mitchell;H Mamon;M Weiser;L Saltz;M Gollub;L Rogak;B Ginos;G Mazza;B Colgrove;G Chang;L Minasian;A Denicoff;G Thanarajasingam;B Musher;T George;A Venook;J Farma;E O'Reilly;J Meyerhardt;Q Shi;D Schrag
Journal / Conference
J Clin Oncol. Jul 20;41(21):3724-3734
Year
2023
Research Committee(s)
Gastrointestinal
PMID
PMID37270691
PMC
PMC10351948
Study Number(s)
CTSU/N1048